Philippe Lucas PhD is a cannabis and psychedelic researcher and President of Sabi Mind, a clinic group focused on increasing access to psychedelic-assisted therapy in the treatment of mental health, pain and problematic substance use, and he is also CEO of Plantchek, which produces on-site analytical tools for the cannabis industry. Philippe was founder and Executive Director of the Vancouver Island Compassion Society, one of Canada’s first medical cannabis dispensaries, and a founding Board member of the Multidisciplinary Association of Psychedelic Studies Canada. More recently he worked as VP, Global Patient Research & Access at Tilray, where he oversaw a comprehensive international clinical and observational cannabis research program. He has been invited to present his research before the Canadian House of Commons and Senate on numerous occasions, and has received a number of accolades for his work and research, including the Americans for Safe Access Researcher of the Year Award 2021, the Cannabis Council of Canada Lifetime Achievement Award, and the Queen Elizabeth II Diamond Jubilee Medal.
